- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
236
236 companies
Almirall
Market Cap: €2.0b
Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.
0O9B
€9.17
7D
-2.1%
1Y
10.9%
Vetoquinol
Market Cap: €892.2m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
0O1O
€75.40
7D
-0.9%
1Y
-21.6%
Genus
Market Cap: UK£1.1b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£16.10
7D
-8.1%
1Y
-9.6%
Viatris
Market Cap: US$9.0b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
0A5V
US$7.55
7D
-2.4%
1Y
-32.8%
Sanofi
Market Cap: €109.7b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
0O59
€89.62
7D
-8.0%
1Y
3.6%
Sanofi
Market Cap: €109.7b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SANP
€89.84
7D
-6.6%
1Y
3.6%
Sandoz Group
Market Cap: CHF 13.7b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZZ
CHF 31.57
7D
-4.2%
1Y
17.5%
Hikma Pharmaceuticals
Market Cap: UK£4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIK
UK£18.30
7D
-2.5%
1Y
1.5%
Bayer
Market Cap: €19.8b
Operates as a life science company worldwide.
0P6S
€20.14
7D
-2.4%
1Y
-25.3%
hVIVO
Market Cap: UK£109.7m
Operates as a pharmaceutical service and contract research company in the United Kingdom.
HVO
UK£0.16
7D
11.2%
1Y
-44.0%
Merck KGaA
Market Cap: €50.1b
Operates as a science and technology company in Germany.
0O14
€115.30
7D
-4.3%
1Y
-24.9%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.5b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
0ILL
€48.33
7D
-1.2%
1Y
-41.3%
Regeneron Pharmaceuticals
Market Cap: US$59.3b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
0R2M
US$551.69
7D
-6.1%
1Y
-39.0%
Euroapi
Market Cap: €227.2m
Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.
0EAP
€2.39
7D
-2.8%
1Y
-17.3%
Merck
Market Cap: US$199.2b
Operates as a healthcare company worldwide.
0QAH
US$77.60
7D
-6.6%
1Y
-38.5%
Hikma Pharmaceuticals
Market Cap: UK£4.0b
Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
HIKL
UK£18.35
7D
-2.8%
1Y
1.8%
Diaceutics
Market Cap: UK£95.1m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
DXRX
UK£1.13
7D
0%
1Y
8.2%
Virbac
Market Cap: €2.5b
Manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.
0NM7
€290.75
7D
-1.9%
1Y
-21.3%
Indivior
Market Cap: UK£857.1m
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDVL
UK£6.87
7D
-3.6%
1Y
-56.0%
Genus
Market Cap: UK£1.1b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNSL
UK£16.26
7D
-7.4%
1Y
-9.9%
Bayer
Market Cap: €19.8b
Operates as a life science company worldwide.
BAYND
€20.06
7D
-0.5%
1Y
-26.8%
Indivior
Market Cap: UK£857.1m
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
UK£6.87
7D
-3.8%
1Y
-56.1%
Sandoz Group
Market Cap: CHF 13.7b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
0SAN
CHF 31.05
7D
-7.9%
1Y
15.4%
Gerresheimer
Market Cap: €1.8b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
0NTI
€53.05
7D
-4.7%
1Y
-46.7%
Teva Pharmaceutical Industries
Market Cap: US$15.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
0LER
US$13.27
7D
-2.8%
1Y
0.3%
Incyte
Market Cap: US$11.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
0J9P
US$56.10
7D
-8.6%
1Y
3.6%
Cosmo Pharmaceuticals
Market Cap: CHF 741.5m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPNZ
CHF 46.05
7D
-11.1%
1Y
-33.4%
Novartis
Market Cap: CHF 163.4b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVNz
CHF 86.25
7D
-6.0%
1Y
0.2%
AstraZeneca
Market Cap: UK£155.2b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£100.08
7D
-7.4%
1Y
-9.5%
Halozyme Therapeutics
Market Cap: US$7.4b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
0J2O
US$58.71
7D
-2.3%
1Y
51.0%
Evolus
Market Cap: US$606.6m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
0K16
US$14.58
7D
0%
1Y
19.9%
Novartis
Market Cap: CHF 163.4b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
0QLR
CHF 86.18
7D
-7.3%
1Y
0.07%
Neurocrine Biosciences
Market Cap: US$9.1b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
0K6R
US$91.16
7D
-4.4%
1Y
-32.9%
Pharming Group
Market Cap: €470.5m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
0QCO
€0.68
7D
-3.1%
1Y
-32.4%
Sarepta Therapeutics
Market Cap: US$5.0b
A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.
0L35
US$50.68
7D
-11.6%
1Y
-58.8%
Pfizer
Market Cap: US$122.4b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
0Q1N
US$21.40
7D
-8.6%
1Y
-18.0%